Thompson Juliet 4

What Happened

• Juliet Thompson, a director of Indivior Pharmaceuticals (INDV), received a grant of 6,518 Restricted Stock Units (RSUs) on 2026-05-13. The filing shows an acquisition of 6,518 RSUs at $0 per unit (typical for awards).
• On 2026-05-12, 1,117 shares were surrendered/withheld to cover tax withholding obligations related to RSU vesting; those shares were reported as disposed at $38.28 each, totaling $42,759. The RSU grant itself is not a cash purchase — it is an award that converts to shares if and when it vests.

Key Details

• Transaction dates and amounts:
  • 2026-05-12: 1,117 shares withheld/surrendered for taxes at $38.28 each = $42,759 (code F).
  • 2026-05-13: Grant of 6,518 RSUs (code A), recorded at $0 per RSU (award value not shown as a cash purchase).
• Shares owned after transaction: The Form 4 did not disclose total shares owned after these transactions.
• Notable footnotes:
  • Shares withheld were used to satisfy tax withholding on RSU vesting (footnote F1).
  • The RSUs vest on the day immediately preceding the annual meeting following the grant date, contingent on continued service (footnote F2).
• Filing timeliness: Reported on 2026-05-14 for transactions on 2026-05-12 and 2026-05-13; this appears to be timely (no late-filing flag indicated).

Context

• RSU grants are common compensation for directors; they are contingent awards that convert to shares only if vesting conditions (here, continued service until the specified vest date) are met. The surrender/withholding of shares to cover taxes is a standard administrative step and does not necessarily signal a change in insider sentiment.